MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-10-2026
Pulmonx Corporation ROCE Ratio 2011-2026 | LUNG
Annual ROCE Ratio Pulmonx Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -99.16 | -67.25 | -52.35 | -38.07 | -24.48 | -12.87 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -12.87 | -99.16 | -49.03 |
Quarterly ROCE Ratio Pulmonx Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -79.2 | -70.26 | -64.28 | -43.64 | -55.71 | -52.73 | -49.57 | -35.74 | -44.26 | -40.71 | -36.81 | -25.49 | -30.31 | -26.6 | -24.3 | -16.67 | -19.03 | -16.58 | -15.61 | -10.16 | -8.23 | -3.94 | 1.16 | 1.93 | 1.93 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.93 | -79.2 | -30.59 |
ROCE Ratio of other stocks in the Medical devices industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
-660.94 | $ 11.02 | 1.06 % | $ 1.65 B |  USA |
 |
Cytosorbents Corporation
CTSO
|
-249.86 | $ 0.6 | -1.66 % | $ 37.3 M | USA |
 |
AxoGen
AXGN
|
-6.09 | $ 32.36 | 1.25 % | $ 1.49 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-50.21 | $ 3.32 | 0.61 % | $ 124 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
-6.16 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
1334.24 | - | -26.83 % | $ 2.62 M | USA |
 |
Helius Medical Technologies
HSDT
|
-528.85 | $ 1.87 | -1.05 % | $ 1.14 M | USA |
 |
Align Technology
ALGN
|
15.77 | $ 173.99 | 0.49 % | $ 13 B | USA |
 |
AdaptHealth Corp.
AHCO
|
5.98 | $ 12.21 | 0.33 % | $ 1.65 B | USA |
 |
Allied Healthcare Products
AHPI
|
-24.19 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-89.32 | - | 24.59 % | $ 44.8 M |  China |
 |
IRIDEX Corporation
IRIX
|
-52.23 | $ 1.02 | 2.01 % | $ 17.3 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-11.39 | - | - | $ 3.31 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-191.02 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
4.09 | $ 282.96 | 1.33 % | $ 7.98 B | USA |
 |
BioSig Technologies
BSGM
|
-53.38 | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
-85.42 | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
14.21 | $ 38.02 | 1.14 % | $ 5.66 K | USA |
 |
Boston Scientific Corporation
BSX
|
14.91 | $ 62.08 | 0.47 % | $ 91.9 B | USA |
 |
LivaNova PLC
LIVN
|
16.62 | $ 62.79 | 0.02 % | $ 3.43 B |  Britain |
 |
LENSAR
LNSR
|
94.46 | $ 5.88 | 3.16 % | $ 70.3 M | USA |
 |
Apollo Endosurgery
APEN
|
-96.4 | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
-14.35 | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
-86.24 | $ 9.12 | 5.07 % | $ 258 M | USA |
 |
Dynatronics Corporation
DYNT
|
-75.2 | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
22.36 | $ 24.2 | 0.33 % | $ 205 M | USA |
 |
CryoLife, Inc.
CRY
|
0.33 | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
268.22 | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
-175.18 | - | -0.97 % | $ 54.4 M | USA |
 |
Inogen
INGN
|
-15.71 | $ 6.49 | 2.53 % | $ 173 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-804.35 | - | 1.15 % | $ 34.5 M | USA |
 |
Aziyo Biologics
AZYO
|
-97.25 | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-46.49 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-124.26 | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
-355.28 | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-22.41 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-10.4 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-344.26 | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
-8.49 | $ 16.42 | 2.82 % | $ 385 M | USA |
 |
Globus Medical
GMED
|
10.49 | $ 91.13 | 0.79 % | $ 12.3 B | USA |
 |
Sintx Technologies
SINT
|
-366.03 | $ 2.8 | 4.48 % | $ 7.77 M | USA |
 |
Butterfly Network
BFLY
|
-44.07 | $ 4.1 | -0.24 % | $ 868 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-36.94 | - | - | $ 955 M | USA |
 |
Stryker Corporation
SYK
|
21.81 | $ 340.42 | 0.37 % | $ 130 B | USA |
 |
BIOLASE
BIOL
|
7261.94 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
0.59 | $ 10.22 | 1.79 % | $ 366 M | USA |
 |
TELA Bio
TELA
|
-534.69 | $ 0.57 | 0.46 % | $ 26.8 M | USA |
 |
Myomo
MYO
|
-126.29 | $ 0.69 | 0.06 % | $ 28.9 M | USA |
 |
Inspire Medical Systems
INSP
|
6.52 | $ 54.12 | 0.19 % | $ 1.59 B | USA |
 |
CONMED Corporation
CNMD
|
9.93 | $ 36.88 | 0.38 % | $ 1.14 B | USA |